文献速递肝病

磁共振成像质子密度脂肪分数与非酒精性脂肪性肝病患者纤维化进展相关

Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Gastroenterology · 2018-04-13

研究对95例经活检证实非酒精性脂肪性肝病的特征明确患者进行随访,基线用磁共振成像质子密度脂肪分数(MRI-PDFF)测量肝脂肪含量,平均1.75年后再次活检。基线无纤维化患者中,MRI-PDFF≥15.7%组纤维化进展比例38.1%,低于15.7%组为11.8%(P=0.067);多变量校正后高肝脂肪组纤维化进展风险显著升高(校正比值比6.7,95%CI 1.01–44.1,P=0.049)。

要点

  • 基线无纤维化者中,MRI-PDFF≥15.7%组纤维化进展比例为38.1%,低于15.7%组为11.8%(P=0.067)。
  • 多变量校正年龄、性别、种族和体重指数后,高肝脂肪组纤维化进展风险显著升高(校正比值比6.7,95%CI 1.01–44.1,P=0.049)。
  • MRI-PDFF测量的较高肝脂肪含量与纤维化进展相关。

核心结论

  • MRI-PDFF测量的较高肝脂肪含量与纤维化进展相关。

研究设计与样本

  • 对95例经活检证实非酒精性脂肪性肝病、特征明确的患者进行随访研究,基线行MRI-PDFF测量,基线和平均1.75年后收集肝活检。

主要发现

  • 基线无纤维化患者中,MRI-PDFF≥15.7%组纤维化进展比例为38.1%,低于15.7%组为11.8%(P=0.067)。
  • 多变量校正年龄、性别、种族和体重指数后,高肝脂肪组纤维化进展风险显著升高(校正比值比6.7,95%CI 1.01–44.1,P=0.049)。

关键数值与推荐

  • 高肝脂肪组定义为MRI-PDFF≥15.7%。
  • 多变量校正模型调整变量包括年龄、性别、种族和体重指数。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Markers are needed to predict progression of nonalcoholic fatty liver disease (NAFLD). The proton density fat fraction, measured by magnetic resonance imaging (MRI-PDFF), provides an accurate, validated marker of hepatic steatosis; however, it is not clear whether the PDFF identifies patients at risk for NAFLD progression. We performed a follow-up study of 95 well-characterized patients with biopsy-proven NAFLD and examined the association between liver fat content and fibrosis progression. MRI-PDFF measurements were made at study entry (baseline). Biopsies were collected from patients at baseline and after a mean time period of 1.75 years. Among patients with no fibrosis at baseline, a higher proportion of patients in the higher liver fat group (MRI-PDFF ≥15.7%) had fibrosis progression (38.1%) than in the lower liver fat group (11.8%) (P = .067). In multivariable-adjusted logistic regression models (adjusted for age, sex, ethnicity, and body mass index), patients in the higher liver fat group had a significantly higher risk of fibrosis progression (multivariable-adjusted odds ratio 6.7; 95% confidence interval 1.01-44.1; P = .049). Our findings associate higher liver fat content, measured by MRI-PDFF, with fibrosis progression.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Ajmera V, Park CC, Caussy C, et al. Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018. PMID: 29660324. doi:10.1053/j.gastro.2018.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。